The purpose of this exploratory study was to examine speech characteristics in individuals with Parkinson’s disease (PD) before and after participation in an 11-week choral singing intervention. Speech characteristics were analyzed using an acoustic measure of vowel space area (VSA) and a standardized speech intelligibility metric. Participants included five males and five females with PD. VSA was derived for the corner vowels (/i/, /u/, /æ/ /α/) produced during a sentence-level task. VSA was expressed as an irregular quadrilateral formed by the first and second formants of these corner vowels. A validated speech intelligibility instrument was administered pre- and posttreatment. VSA significantly increased posttreatment, which suggests greater tongue excursion during vowel articulation. Speech intelligibility scores significantly increased posttreatment, thus reflecting improved speech communication. Results suggest that choral singing may be a viable speech treatment for some individuals with PD. A large-scale randomized controlled trial is warranted.
AzekawaM.LagasseA. B. (2018). Singing exercises for speech and vocal abilities in individuals with hypokinetic dysarthria: A feasibility study. Music Therapy Perspectives, 36, 40–49.
2.
BakerF.WigramT.GoldC. (2005). The effects of a song-singing programme on the affective speaking intonation of people with traumatic brain injury. Brain Injury, 19, 519–528.
3.
BeckA. T.SteerR. A.BrownG. K. (1996). Beck Depression Inventory®–II. San Antonio, TX: Pearson.
4.
BradlowA. R.TorrettaG. M.PisoniD. B. (1996). Intelligibility of normal speech I: Global and fine-grained acoustic-phonetic talker characteristics. Speech Communication, 20, 255–272.
5.
BrownS.MartinezM. J.ParsonsL. M. (2006). Music and language side by side in the brain: A PET study of the generation of melodies and sentences. European Journal of Neuroscience, 23, 2791–2803.
6.
DarleyF. L.AronsonA. E.BrownJ. R. (1969). Clusters of deviant speech dimensions in the dysarthrias. Journal of Speech, Language, and Hearing Research, 12, 462–496.
7.
DavidowJ. H.BotheA. K.AndreattaR. D.YeJ. (2009). Measurement of phonated intervals during for fluency-inducing conditions. Journal Speech, Language, and Hearing Research, 52, 188–205.
8.
Di BenedettoP.CavazzonM.MondoloF.RugiuG.PeratonerA.BiasuttiE. (2009). Voice and choral singing treatment: A new approach for speech and voice disorders in Parkinson’s disease. European Journal of Physical and Rehabilitation Medicine, 45(1), 13–19.
9.
DuffyJ. R. (2005). Motor speech disorders: Substrates, differential diagnosis, and management. St. Louis, Mo: Elsevier Mosby.
10.
ElefantC.BakerF. A.LotanM.LagesenS. K.SkeieG. O. (2012). The effect of group music therapy on mood, speech, and singing in individuals with Parkinson’s disease—A feasibility study. Journal of Music Therapy, 49, 278–302.
El SharkawiA.RamigL.LogemannJ. A.PauloskiB. R.RademakerA. W.SmithC. H.WernerC. (2002). Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): A pilot study. Journal of Neurology, Neurosurgery & Psychiatry, 72, 31–36.
13.
FeenaughtyL.TjadenK.BenedictR. H.Weinstock-GuttmanB. (2013). Speech and pause characteristics in multiple sclerosis: A preliminary study of speakers with high and low neuropsychological test performance. Clinical Linguistics & Phonetics, 27, 134–151.
14.
FoggL.TalmageA. (2011). The CeleBRation Choir: Establishing community group choral singing for people living with neurological conditions. Psychomusicology: Music, Mind and Brain, 21, 264–267.
15.
FolsteinM. F.FolsteinS. E.McHughP. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
16.
FoxC. M.MorrisonC. E.RamigL. O.SapirS. (2002). Current perspectives on the Lee Silverman Voice Treatment (LSVT) for individuals with idiopathic Parkinson disease. American Journal of Speech-Language Pathology, 11, 111–123.
17.
GaserC.SchlaugG. (2003). Brain structures differ between musicians and non-musicians. Journal of Neuroscience, 23, 9240–9245.
18.
HaneishiE. (2001). Effects of a music therapy voice protocol on speech intelligibility, vocal acoustic measures, and mood of individuals with Parkinson’s disease. Journal of Music Therapy, 38, 273–290.
19.
HealeyE. C.MallardA. R.AdamsM. R. (1976). Factors contributing to the reduction of stuttering during singing. Journal of Speech and Hearing Research, 19, 475–480.
20.
JungblutM.HuberW.MaisC.SchnitkerR. (2014). Paving the way for speech: Voice-training-induced plasticity in chronic aphasia and apraxia of speech—Three single cases. Neural Plasticity, 2014, Article 841982.
21.
KimH.Hasegawa-JohnsonM.PerlmanA. (2011). Vowel contrast and speech intelligibility in dysarthria. Folia Phoniatrica et Logopaedica, 63(4), 187–194.
22.
KlattD. H.KlattL. C. (1990). Analysis, synthesis, and perception of voice quality variations among female and male talkers. The Journal of the Acoustical Society of America, 87, 820–857.
23.
KleberB.VeitR.BirbaumerN.GruzelierJ.LotzeM. (2010). The brain of opera singers: Experience dependent changes in functional activation. Cerebral Cortex, 20, 1144–1152.
24.
KwonH. B. (2010). Gender difference in speech intelligibility using speech intelligibility tests and acoustic analyses. The Journal of Advanced Prosthodontics, 2(3), 71–76.
25.
LansfordK. L.LissJ. M. (2014). Vowel acoustics in dysarthria: Speech disorder diagnosis and classification. Journal of Speech, Language, and Hearing Research, 57, 57–67.
26.
McRaeP. A.TjadenK.SchooningsB. (2002). Acoustic and perceptual consequences of articulatory rate change in Parkinson disease. Journal of Speech, Language, and Hearing Research, 45, 35–50.
27.
MilenkovicP. (2001). TF32. Madison: University of Wisconsin–Madison.
28.
MillerN.NobleE.JonesD.BurnD. (2006). Life with communication changes in Parkinson’s disease. Age and Ageing, 35, 235–239.
29.
NeelA. T. (2008). Vowel space characteristics and vowel identification accuracy. Journal of Speech, Language, and Hearing Research, 51, 574–585.
30.
ÖzdemirE.NortonA.SchlaugG. (2006). Shared and distinct neural correlates of singing and speaking. NeuroImage, 33, 628–635.
31.
RamigL. O.FoxC.SapirS. (2008). Speech treatment for Parkinson’s disease. Expert Review of Neurotherapeutics, 8, 297–309.
32.
RamigL. O.SapirS.FoxC.CountrymanS. (2001). Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson’s disease: A comparison with untreated patients and normal age-matched controls. Movement Disorders, 16, 79–83.
33.
Recommended practices for speech quality measurements. (1969). IEEE Transactions on Audio and Electroacoustics, 17, 225–246.
34.
RichardsonK.SussmanJ. E.StathopoulosE. T. (2014). The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: A preliminary analysis. Journal of Communication Disorders, 52, 44–64.
35.
SapirS.SpielmanJ. L.RamigL. O.StoryB. H.FoxC. (2007). Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: Acoustic and perceptual findings. Journal of Speech, Language, and Hearing Research, 50, 899–912.
36.
SchlaugG. (2001). The brain of musicians: A model for functional and structural plasticity. Annals of the New York Academy of Sciences, 930, 281–299.
37.
SchlaugG.NortonA.MarchinaS.ZipseL.WanC. (2010). From singing to speaking: Facilitating recovery from nonfluent aphasia. Future Neurology, 5, 657–665.
38.
ShihL. C.PielJ.WarrenA.KraicsL.SilverA.VanderhorstV.. . . TarsyD. (2012). Singing in groups for Parkinson’s disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disorders. Parkinsonism & Related Disorders, 18, 548–552.
39.
SkoddaS.GrönheitW.SchlegelU. (2012). Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS ONE, 7(2), e32132.
40.
SkoddaS.VisserW.SchlegelU. (2011a). Gender-related patterns of dysprosody in Parkinson disease and correlation between speech variables and motor symptoms. Journal of Voice, 25, 76–82.
41.
SkoddaS.VisserW.SchlegelU. (2011b). Vowel articulation in Parkinson’s disease. Journal of Voice, 25, 467–472.
42.
SmithM. E.RamigL. O.DromeyC.PerezK. S.SamandariR. (1995). Intensive voice treatment in Parkinson disease: Laryngostroboscopic findings. Journal of Voice, 9, 453–459.
43.
SpielmanJ. L.BorodJ. C.RamigL. O. (2003). The effects of intensive voice treatment on facial expressiveness in Parkinson disease: Preliminary data. Cognitive and Behavioral Neurology, 16, 177–188.
44.
StathopoulosE. T.HuberJ. E.RichardsonK.KamphausJ.DeCiccoD.DarlingM.. . . SussmanJ. E. (2014). Increased vocal intensity due to the Lombard effect in speakers with Parkinson’s disease: Simultaneous laryngeal and respiratory strategies. Journal of Communication Disorders, 48, 1–17.
45.
TannerM.RammageL.LiuL. (2015). Does singing and vocal strengthening improve vocal ability in people with Parkinson’s disease?Arts & Health: An International Journal for Research, Policy and Practice, 8, 199–212.
46.
ThautC. P. (2014). Vocal intonation therapy (VIT). In ThautM. H.HoembergV. (Eds.), Handbook of neurologic music therapy (pp. 179–184). New York, NY: Oxford University Press.
47.
ThautM. H.McIntoshG. C.McIntoshK. W.HömbergV. (2001). Auditory rhythmicity enhances movement and speech motor control in patients with Parkinson’s disease. Functional Neurology, 16, 163–172.
48.
ThautM. H.McIntoshG. C.RiceR. R. (1996). Rhythmic auditory stimulation in gait training for Parkinson’s disease patients. Movement Disorders, 11, 193–200.
49.
TomainoC. M. (2012). Effective music therapy techniques in the treatment of nonfluent aphasia. The Neurosciences and Music IV Learning and Memory, 1252, 312–317.
50.
TurnerG. S.TjadenK.WeismerG. (1995). The influence of speaking rate on vowel space and speech intelligibility for individuals with amyotrophic lateral sclerosis. Journal of Speech, Language, and Hearing Research, 38, 1001–1013.
51.
Van RiperC. (1978). Speech correction: Principles and methods (6th ed.). Englewood Cliffs, NJ: Prentice Hall.
52.
WanC. Y.RüüberT.HohmannA.SchlaugG. (2010). The therapeutic effects of singing in neurological disorders. Music Perception: An Interdisciplinary Journal, 27, 287–295.
53.
WatsonP. J.MunsonB. (2008). Parkinson’s disease and the effect of lexical factors on vowel articulation. The Journal of Acoustical Society of America, 124, 291–295.
54.
WeinerW.SingerC. (1989). Parkinson’s disease and nonpharmacologic treatment programs. Journal of American Geriatric Society, 37, 359–363.
55.
WeismerG.JengJ. Y.LauresJ. S.KentR. D.KentJ. F. (2001). Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders. Folia Phoniatrica et Logopaedica, 53(1), 1–18.
56.
WenkeR. J.CornwellP.TheodorosD. G. (2010). Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria. International Journal of Speech Language Pathology, 12, 203–220.
57.
WinerB. J. (1962). Statistical principles in experimental design. New York, NY: McGraw-Hill.
58.
YingerO. S.LapointeL. L. (2012). The effects of participation in a group music therapy voice protocol (G-MTVP) on the speech of individuals with Parkinson’s disease. Music Therapy Perspectives, 30(1), 25–31.
59.
YorkstonK. M.BeukelmanD. R.HakelM.DorseyM. (1996). Speech intelligibility test. Lincoln, NE: Institute for Rehabilitation Science and Engineering at Madonna Rehabilitation Hospital.
